Mirac Proteins
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application PCT/US2010/026611, filed Mar 9, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,709,755 | Mirac Proteins In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| US 9,464,284 | Mirac Proteins In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| US 9,637,734 | Mirac Proteins In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| US 9,637,735 | Mirac Proteins In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| US 9,994,841 | Mirac Proteins In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| US 11,718,844 | Mirac Proteins In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| US 9,982,252 | Mirac Proteins In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| Application 18/334,769 | Mirac Proteins Pending Not granted | BioAtla, Inc. | Pending | Not granted |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by BioAtla Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.